Mannkind (MNKD) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.61% |
| Dec 31, 2025 | 66.88% |
| Sep 30, 2025 | -155.68% |
| Jun 30, 2025 | 238.48% |
| Mar 31, 2025 | -95.98% |
| Dec 31, 2024 | 310.76% |
| Sep 30, 2024 | -204.87% |
| Jun 30, 2024 | 122.74% |
| Mar 31, 2024 | 308.64% |
| Dec 31, 2023 | 96.48% |
| Sep 30, 2023 | -199.77% |
| Jun 30, 2023 | 832.81% |
| Mar 31, 2023 | -60.40% |
| Dec 31, 2022 | 880.23% |
| Sep 30, 2022 | 72.16% |
| Jun 30, 2022 | -156.05% |
| Mar 31, 2022 | 200.88% |
| Dec 31, 2021 | -198.41% |
| Sep 30, 2021 | 2,360.39% |
| Jun 30, 2021 | -78.79% |
| Mar 31, 2021 | 96.38% |
| Dec 31, 2020 | 12,325.00% |
| Sep 30, 2020 | -98.51% |
| Jun 30, 2020 | 737.50% |
| Mar 31, 2020 | -98.65% |
| Dec 31, 2019 | 502.39% |
| Sep 30, 2019 | -212.67% |
| Jun 30, 2019 | 93.68% |
| Mar 31, 2016 | 262.03% |
| Dec 31, 2015 | -74.35% |
| Sep 30, 2015 | -72.83% |
| Jun 30, 2015 | 7.88% |
| Mar 31, 2015 | -15.31% |
| Dec 31, 2014 | -47.58% |
| Sep 30, 2014 | 14.64% |
| Jun 30, 2014 | 486.09% |
| Mar 31, 2014 | -77.15% |
| Dec 31, 2013 | 2,580.87% |
| Sep 30, 2013 | 74.24% |
| Jun 30, 2013 | -90.95% |
| Mar 31, 2013 | 2,144.62% |
| Dec 31, 2012 | -47.58% |
| Sep 30, 2012 | -0.80% |
| Jun 30, 2012 | -61.30% |
| Mar 31, 2012 | 108.39% |
| Dec 31, 2011 | -73.91% |
| Sep 30, 2011 | -85.57% |
| Jun 30, 2011 | 106.52% |
| Mar 31, 2011 | -49.35% |
| Dec 31, 2010 | 153.05% |